Graham Robinson is the chair of the firm's Corporate Practice Group and a member of the firm's Mergers and Acquisitions Group. He joined the firm in 2000.
Practice
Mr. Robinson represents technology and life sciences companies in a broad range of transactions and general corporate matters. His clients range from startup companies to large public companies. Mr. Robinson has a particular focus on mergers and acquisitions transactions for his clients. He has represented corporations, special committees and private equity funds in a variety of business combination transactions, both domestically and overseas. Mr. Robinson also serves as regular counsel to several private equity funds and hedge funds.
In 2011, Mr. Robinson was named by the Boston Business Journal as one of its "40 under 40" business and civic leaders in the city of Boston.
Representative Transactions
- Represented Skyworks Solutions in its acquisition of SiGe Semiconductor
- Represented Analog Devices in its acquisition of Lyric Semiconductor
- Represented Arsenal Medical in its separation into 480 Biomedical and Arsenal Medical
- Represented PerkinElmer in its acquisitions of Caliper Life Sciences, Packard BioScience, ViaCell, and the Newborn Metabolic Screening Business of Pediatrix Medical Group
- Represented Taligen Therapeutics in its sale to Alexion Pharmaceuticals
- Represented Prism Pharmaceuticals in its sale to Baxter International
- Represented Arbor Networks in its sale to Danaher
- Represented Alnara Pharmaceuticals in its sale to Eli Lilly
- Represented Takeda in its acquisition of IDM Pharma
- Represented Analog Devices in its $375 million notes offering
- Represented Wireless Generation in its acquisition of Writers' Express
- Represented Sapphire Therapeutics in its sale to Helsinn Healthcare
- Represented Progress Software in its acquisition of IONA Technologies PLC by means of a scheme of arrangement under Irish law
- Represented Arlington Tankers in its merger with General Maritime
- Represented PerkinElmer in the sale of its fluid testing business to Caleb Brett, the sale of its aerospace business to Eaton, the sale of its semiconductor business to Tara Capital, and the sale of its detection systems business to L-3 Communications
- Represented Bayer in its acquisition of the Citracal business from Mission Pharmacal
- Represented Savient Pharmaceuticals in the sale of its global biologics manufacturing business to Ferring, the sale of its oral liquid pharmaceuticals business to Close Brothers Private Equity, in its “modified Dutch auction” self-tender offer, its $31 million registered direct offering and its $66 million common stock offering
- Represented Lucent in its acquisition of Riverstone Networks
- Represented Eyetech in its sale to OSI Pharmaceuticals
- Represented Arbor Networks in its acquisition of Ellacoya Networks
- Represented the underwriters in Evercore Partners’ initial public offering
- Represented Memory Pharmaceuticals in its initial public offering
- Represented KLS Professional Advisors Group in its sale to Boston Private
- Represented Kobren Insight Management in its sale to E*TRADE
- Represented Alpharma in its collaboration with IDEA AG
- Represented Sotheby’s International Realty in its sale to Cendant
- Represented Johnson & Johnson in its acquisition of Egea Biosciences and its acquisition of Link Spine Group
- Represented The Thomson Corporation in it acquisition of Information Holdings and its acquisition of Biological Abstracts
Professional Activities
Mr. Robinson is a member of the American Bar Association.
Honors and Awards
- Selected as a 2011 Boston Business Journal 40-under-40 honoree for his professional accomplishments and community involvement
Publications
Graham Robinson and David B.H. Martin, “To be or Not to be ‘Filed’,” Insights (September 2003).
